CAPE Improves Vanin-1/AKT/miRNA-203 Signaling Pathways in DSS-induced Ulcerative Colitis. Biomedical Research and Therapy, [S. l.], v. 9, n. 9, p. 5313–5325, 2022. DOI: 10.15419/bmrat.v9i9.769. Disponível em: https://preservation.bmrat.org/index.php/BMRAT/article/view/769.. Acesso em: 15 nov. 2024.